Atlas Trials

Consolidative Use of Radiotherapy to Block Oligoprogression in Patients With Metastatic Melanoma

Clinical trial NCT07112170 · RECRUITING

Trial details

NCT number
NCT07112170
Sponsor
University Health Network, Toronto
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Metastatic MelanomaOligoProgressive Metastatic Disease
Start date
2025-07-24
Primary completion
2027-07-24
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.